#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fms-like tyrosine kinase 3 positive B-cell lymphoma Lennox-Gastaut syndrome Neuroendocrine cell hyperplasia of infancy Pulmonary alveolar haemorrhage Alpha-1 antitrypsin deficiency Idiopathic intracranial hypertension Congenital growth hormone deficiency Glomerulonephritis chronic Hepatitis D Rhabdomyosarcoma recurrent Non-small cell lung cancer Progressive supranuclear palsy VEXAS syndrome Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Life with Disease Pemphigoid – Diagnostics Leiomyosarcoma metastatic Glomerulonephritis rapidly progressive Progressive supranuclear palsy – Life with Disease X-linked lymphoproliferative syndrome – Diagnostics Choroid melanoma – Diagnostics CADASIL – Trials in Disease Idiopathic inflammatory myopathy – Trials in Disease Urea cycle disorder – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluoroethyltyrosine F-18 Elranatamab Datopotamab Deruxtecan Cabotegravir Bi 3032950 Isoflurane Pc14586 VOTOPLAM Tucatinib Upacicalcet Sodium Hydrate Ivabradine Highly Refined Fish Oil Glucose, Anhydrous Mavacamten Azd8421 Human Coagulation Factor Vii Pevonedistat Clofutriben Ab-729 Magnesium Stearate More therapies…

    Learn about Your Condition

    Haemorrhoids Pyelonephritis Pain in extremity Genital herpes simplex Bladder cancer Meningioma Ventricular tachycardia Crigler-Najjar syndrome Nervous system disorder Cardiac disorder Ataxia telangiectasia Metastases to meninges Patent ductus arteriosus Perineal injury Medullary thyroid cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastrooesophageal cancer

  • Evaluation of Safety and Efficacy of MK-2870 and Paclitaxel in Second-Line Treatment of Advanced/Metastatic Gastroesophageal Adenocarcinoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • H2-Receptor Antagonist
    France Germany Italy Norway

  • A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zanidatamab
    France Spain

  • A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Tislelizumab
    Austria Czechia France Italy Poland Spain

  • A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • FRUQUINTINIB
    • Tipiracil Hydrochloride
    • Trifluridine
    France Germany Spain

  • Study of Simvastatin with Nivolumab and Oxaliplatin for Patients with Advanced Stomach or Esophageal Cancer with ARID1A Mutation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Human epidermal growth factor receptor negative
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Simvastatin
    • Capecitabine
    • Fluorouracil
    Italy

  • Study on Sertraline with Immunochemotherapy for Patients with Advanced Gastroesophageal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Sertraline
    Austria
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!